Lymphoscintigraphy with 123I-labelled epidermal growth factor.
We have used 123I-labelled epidermal growth factor (EGF) scans to study 14 patients with advanced cervical cancer. Abnormal lymph node imaging was seen most clearly 6-8 h after the injection and revealed abnormal uptake by pelvic lymph nodes in 11 patients. 4 of these 11 had abnormal computerised tomographic and ultrasound scans; in the other 7 conventional radiology did not confirm the presence of disease.
Schatten
C
C
1st Department of Obstetrics and Gynaecology, University of Vienna, Austria.
Pateisky
N
N
Vavra
N
N
Ehrenbock
P
P
Angelberger
P
P
Sivolapenko
G
G
Epenetos
A
A
D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging*; D004815:Epidermal Growth Factor; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging*; D010388:Pelvis; D014055:Tomography, Emission-Computed; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging*
D007457:Iodine Radioisotopes; D004815:Epidermal Growth Factor